In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks discussing the potential role of GLP-1 therapies in alcohol and substance use disorders, risk factors associated with long-term opioid prescribing, patient motivation and readiness to taper opioids for chronic pain, national trends in ADHD medication prescribing, and more!

• GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer Published in the Journal of Endocrine Society, October 2025
• A national cohort study of long-term opioid prescription and sociodemographic and health care-related risk factors Published in Communications Medicine, September 2025
• Patient Motivation to Reduce or Discontinue Opioids for Chronic Pain: Self-efficacy, Barriers, and Readiness to Change Published in the Clinical Journal of Pain, January 2024
• Population-Level Trends in Attention-Deficit/Hyperactivity Disorder Medication Prescribing Published in JAMA Network Open, December 2025
• Increased Avoidance Learning in Chronic Opioid Users Published in JAMA Pyschiatry, November 2025